Infectious Disease Control
MTD Group takes part in the global effort to accelerate the COVID-19 vaccination, thanks to its new Low Dead Space syringes
LUGANO, Switzerland, May 28, 2021 /PRNewswire/ -- In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of individuals that can benefit from the available vaccine vials. In particular, the use of low dead space (LDS) syringes can ...
2021-05-28 03:49
2942
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand
- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine DARMSTADT,...
2021-05-26 20:00
2992
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete RHB-107's ongoing Phase 2/3 study is enrolling U.S. non-hospitalized p...
2021-05-26 19:12
9795
TCI Co., Ltd. named as one of Asia's fastest growing companies by The Financial Times
TAIPEI, May 25, 2021 /PRNewswire/ -- TCI Co., Ltd. (8436. TWO), a leading nutraceutical ODM company, has earned a position in the exclusive ranking of High-Growth Companies inAsia-Pacific 2021. TCI, has been ranked top 15 among Taiwanese companies, registering an absolute growth rate of 207.6% an...
2021-05-26 11:07
2889
Aussie LegalTech Startup Goes Global With COVID-19 Diagnosis Tool
* Australian LegalTech startup, Rulestar, is taking its automation platform global and expanding beyond the legal industry. * Rulestar has released an automated COVID-19 diagnosis tool as a new proof-of-concept product. * This demonstrates how automation technologies can improve decision-mak...
2021-05-25 22:25
1918
Aon's New Vaccine Supply Chain Solution to Benefit Response Fund for the World Health Organization
Aon will donate all 2021 revenues from new solution that protects global COVID-19 vaccine shipments to the COVID-19 Solidarity Response Fund. CHICAGO, May 25, 2021 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and hea...
2021-05-25 21:00
6846
Aiming for Zero Leprosy: 30th Anniversary of World Health Assembly Resolution and WHO Global Leprosy Strategy 2021-2030 Are Opportunities to Accelerate Efforts against the Disease
TOKYO, May 24, 2021 /PRNewswire/ -- Thirty years ago this month, the World Health Assembly (WHA) adopted a resolution to eliminate leprosy as a public health problem. Today, as the 74th WHA gets under way, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa is urging countries not to o...
2021-05-24 15:00
1558
Chinese president addresses global health summit
BEIJING, May 24, 2021 /PRNewswire/ -- Chinese President Xi Jinping attended the Global Health Summit and delivered a speech via video link inBeijing on Friday.   The summit was co-hosted by Italy, rotating presidency of G20, and the European Commission. In his speech, Xi urged ...
2021-05-24 09:43
3077
Trip.com Group donates 400 oxygen concentrators to India to provide support during the COVID-19 crisis
SINGAPORE, May 24, 2021 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, has launched a medical relief initiative this month to helpIndia tackle oxygen equipment shortages during the COVID-19 crisis. Trip.com Group has donated 400 oxygen concentrators to its indus...
2021-05-24 09:00
2557
A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal
SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the 24th that CNPharm, its major shareholding bio tech company, published an article containing the research results of CP-COV03, a Niclosamide-based oral treatment for COVID-19 based on its proprietar...
2021-05-24 08:16
2377
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...
2021-05-23 00:39
9746
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine
CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing a fully integrated end-to-end contract develop...
2021-05-23 00:00
9598
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response
- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 - Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody t...
2021-05-22 05:22
9749
CGTN：China makes new pledges to help developing countries defeat COVID-19
BEIJING, May 22, 2021 /PRNewswire/ -- China on Friday announced several new measures to help developing countries tackle the COVID-19 pandemic and its sweeping impacts, pledging to contribute$3 billion in the next three years and provide more vaccines.   Addressing the Global H...
2021-05-22 01:16
4897
World Health Organisation Declares Dominica as Latest Country to Eliminate Mother-to-Child HIV Transmission
LONDON, May 21, 2021 /PRNewswire/-- The Commonwealth of Dominica has received certification from the World Health Organisation for eliminating mother-to-child HIV and syphilis transmission after witnessing no recorded cases over the last four years.Dominica is the latest Caribbean country to ach...
2021-05-21 10:00
2834
Island Pharmaceuticals granted key patent for ISLA-101 in the United States
* Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office * Patent underpins Island's drug repurposing strategy to rapidly and efficiently develop antiviral therapies with a key focus being mosquito borne viral diseases, such as dengue fever. * Around 3...
2021-05-19 19:30
2411
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing
ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ad...
2021-05-18 21:00
2041
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
2021-05-18 11:50
3141
AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community
The "AIforCOVID Imaging Archive" platform enables the sharing of radiographic images from COVID-19 patients and development of leading-edge Artificial Intelligence-based methods for predicting clinical developments of the disease caused by SARS-CoV-2. The platform has been promoted and implement...
2021-05-18 04:44
1682
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines
PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...
2021-05-17 20:54
2436
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 291 media titles]
2026-01-05 12:14
Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45
Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 280 media titles]
2026-01-07 10:00
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 280 media titles]
2026-01-01 10:00
Ensign InfoSecurity Maintains Top 10 Global Managed Security Service Providers (MSSP) Ranking; Remains Asia Pacific's Leading MSSP for the Fourth Year
[Picked up by 270 media titles]
2026-01-07 08:00Most Read
China Daily Launches "China Bound" -- An English-Language Smart-Tourism Service Platform for International Travelers
2026-01-01 17:04
8631
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
2026-01-01 10:00
7743
Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange
2026-01-02 17:41
7120
